<DOC>
	<DOCNO>NCT00916994</DOCNO>
	<brief_summary>Title : One-arm , international , multi-center competitive recruitment , prospective study ass safety efficacy OrthoSpace 's InSpace™ rotator cuff tear subject schedule surgery rotator cuff - A pivotal study Device : OrthoSpace 's Biodegradable Implanted Balloon ( InSpace ) Study population : Rotator Cuff tear subject schedule arthroscopy . Number subject : Up 70 subject data analysis . Number sit : At least 4 site Israel . Main Inclusion criterion : Informed consent , diagnose Rotator Cuff tear . Main Exclusion criterion : Former surgery affect shoulder , sever illness , significant shoulder co morbidity . Follow period : 12 month . Visits hospital discharge 1-2 day post implantation , 7-10 day post implantation , 3 week post implantation , 6 week post implantation , 3,6 12 month post implantation . Primary goal : To assess safety SpaceGuard Rotator Cuff tear subject . Secondary goal : To assess effectiveness SpaceGuard study population . The effectiveness assess term good position SpaceGuard subsequent follow-up non migration , surgeon satisfaction , pain relief time pain relief , Range Motion ( ROM ) time ROM SpaceGuard . Primary end point : Serious Adverse Event rate relate device and/or system complication . Secondary end point : Surgeon dissatisfaction follow deployment SpaceGuard , migration balloon show ultrasound/ X-ray/MRI relevant follow-up visit , lose ROM pain enhancement .</brief_summary>
	<brief_title>Prospective Study Safety Efficacy InSpace™ Rotator Cuff Tear Subjects</brief_title>
	<detailed_description>The OrthoSpace 's InSpace™ biodegradable sub-acromial spacer ( balloon ) insert end routine arthroscopy humerus head acromion .</detailed_description>
	<criteria>1 . Age 18 old . 2 . Diagnosed Rotator Cuff tear schedule surgery . 3 . XRay treat shoulder unrelated pathology imaging ( ultrasound MRI ) show Rotator Cuff tear . 4 . Persistent pain functional disability least 4 month . 5 . Documented failure conservative treatment . 6 . Blood work two week implantation follow : Normal CBC Normal electrolytes ( potassium , chloride , phosphorous , sodium ) Absolute neutrophil count ( ANC ) ≥ 1,800 cells/mm3 Platelets ≥ 100,000 cells/mm3 Hemoglobin ≥ 10.0 g/dl Adequate renal function , serum creatinine ≤ 2.0 mg/dl Adequate liver function , serum bilirubin &lt; 2.0 mg/dl Adequate liver function SGOT/SGPT &lt; 2.5 x upper normal limit Normal value PT , PTT INR test 7 . Negative HIV Hepatitis B C 8 . Mentally physically able fully comply protocol include adhere followup schedule requirement 9 . For Woman Child Bearing Potential ( WOCBP ) , negative pregnancy test willingness use birth control study . 10 . Singed Informed Consent Form . 1 . Evidence significant osteoarthritis cartilage damage shoulder . 2 . Evidence glenohumeral instability . 3 . Previous surgery shoulder . 4 . Evidence major joint trauma , infection , necrosis shoulder . 5 . Patients unable provide inform consent due language barrier mental status . 6 . Patients major medical condition would affect quality life influence result study ( Including , limit HIV , hepatitis , active malignancy past 5 year , transmural MI , CVA impair neurological status , CHF unstable angina past 6 month ) . 7 . Patients unwilling follow duration study . 8 . Acute infection require intravenous antibiotic time screen . 9 . Other shoulder pain unknown etiology . 10 . Paget 's disease , osteomalacia metabolic bone disease . 11 . Severe diabetes mellitus require daily insulin management . 12 . Bleeding disorder . 13 . Known cognitive disorder . 14 . Concurrent participation clinical study . 15 . Physician objection . 16 . Subjects sign cervical root irritation . 17 . Chronic lung disease 18 . Trauma subject 19 . For WOCBP , positive pregnancy test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Rotator Cuff Tear</keyword>
</DOC>